{"schema_version":"secwatch.filing_event.v1","accession":"0000877860-26-000136","form_type":"8-K","ticker":"NHI","cik":"0000877860","company_name":"NATIONAL HEALTH INVESTORS INC","filed_at":"2026-05-04T23:59:59+00:00","discovered_at":"2026-05-14T18:02:33.850879+00:00","generated_at":"2026-05-15T00:10:32.175541+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"NHI Q1 EPS +11% to $0.82 but cuts FY2026 FFO guidance to $4.74-$4.79","bullets":["Net income per diluted share $0.82 (+10.8% YoY); NAREIT FFO $1.23 (+7.9%).","Normalized FFO guidance cut from $4.94-$4.99 to $4.74-$4.79; Normalized FAD lowered to $240.6-$243.7M.","Agreed to sell NHC-leased portfolio (32 SNFs + 3 ILFs) for $560M net cash, expected close July 1, 2026.","Year-to-date invested $212.4M including $106.9M for seven CO senior housing properties (May 2026).","Same-store SHOP NOI declined 2.4% on occupancy headwinds; leverage 4.0x within target."],"urls":{"canonical":"https://secwatch.observer/filing/0000877860-26-000136","json":"https://secwatch.observer/filing/0000877860-26-000136.json","markdown":"https://secwatch.observer/filing/0000877860-26-000136.md","text":"https://secwatch.observer/filing/0000877860-26-000136.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/877860/000087786026000136/0000877860-26-000136-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/877860/000087786026000136/nhi-20260504.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T00:10:32.175541+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"b038c97cb7fcfa55a2a42255cb61f8fe8a18791b","claim":"NATIONAL HEALTH INVESTORS INC reported the quarter ended March 31, 2026 results: EPS $0.82 per diluted share.","evidence_excerpt":"Net income attributable to common stockholders per diluted share for the quarter ended March 31, 2026 increased by 10.8% to $0.82 per share compared to $0.74 per share for the same period in the prior year.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/877860/000087786026000136/0000877860-26-000136-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the quarter ended March 31, 2026"},{"label":"EPS","value":"$0.82 per diluted share"},{"label":"Result","value":"reported results"}]},{"claim_id":"d19a77360d61351dd8eade3a58d7b6f82bf6875f","claim":"NATIONAL HEALTH INVESTORS INC updated its 2026 full year guidance (lowered).","evidence_excerpt":"NHI is updating its 2026 full year guidance range as follows: • NAREIT FFO per diluted share from a range of $4.94 - $4.99 to a range of $4.74 - $4.79; • Normalized FFO per diluted share from a range of $4.94 - $4.99 to a range of $4.74 - $4.79; and • Normalized FAD from a range of $248.9 million - $251.4 million to a range of $240.6 million - $243.7 million.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/877860/000087786026000136/0000877860-26-000136-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"2026 full year"},{"label":"Guidance","value":"lowered"},{"label":"Result","value":"guidance update"}]}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}